Advertisement
Canada markets close in 5 hours 6 minutes
  • S&P/TSX

    21,994.00
    +122.04 (+0.56%)
     
  • S&P 500

    5,062.97
    +52.37 (+1.05%)
     
  • DOW

    38,471.16
    +231.18 (+0.60%)
     
  • CAD/USD

    0.7319
    +0.0017 (+0.24%)
     
  • CRUDE OIL

    82.27
    +0.37 (+0.45%)
     
  • Bitcoin CAD

    91,262.52
    +681.47 (+0.75%)
     
  • CMC Crypto 200

    1,444.07
    +29.31 (+2.07%)
     
  • GOLD FUTURES

    2,332.10
    -14.30 (-0.61%)
     
  • RUSSELL 2000

    2,001.87
    +34.40 (+1.75%)
     
  • 10-Yr Bond

    4.5840
    -0.0390 (-0.84%)
     
  • NASDAQ

    15,663.59
    +212.29 (+1.37%)
     
  • VOLATILITY

    16.29
    -0.65 (-3.84%)
     
  • FTSE

    8,037.61
    +13.74 (+0.17%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • CAD/EUR

    0.6837
    -0.0013 (-0.19%)
     

What You Need To Know About Repro Med Systems, Inc.'s (NASDAQ:KRMD) Investor Composition

A look at the shareholders of Repro Med Systems, Inc. (NASDAQ:KRMD) can tell us which group is most powerful. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. I quite like to see at least a little bit of insider ownership. As Charlie Munger said 'Show me the incentive and I will show you the outcome.

Repro Med Systems is not a large company by global standards. It has a market capitalization of US$163m, which means it wouldn't have the attention of many institutional investors. Our analysis of the ownership of the company, below, shows that institutions own shares in the company. Let's take a closer look to see what the different types of shareholders can tell us about Repro Med Systems.

See our latest analysis for Repro Med Systems

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About Repro Med Systems?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

ADVERTISEMENT

We can see that Repro Med Systems does have institutional investors; and they hold a good portion of the company's stock. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Repro Med Systems, (below). Of course, keep in mind that there are other factors to consider, too.

earnings-and-revenue-growth
earnings-and-revenue-growth

Our data indicates that hedge funds own 30% of Repro Med Systems. That's interesting, because hedge funds can be quite active and activist. Many look for medium term catalysts that will drive the share price higher. The company's largest shareholder is Horton Capital Management, LLC, with ownership of 24%. In comparison, the second and third largest shareholders hold about 12% and 5.5% of the stock. Additionally, the company's CEO Linda Tharby directly holds 2.2% of the total shares outstanding.

We also observed that the top 6 shareholders account for more than half of the share register, with a few smaller shareholders to balance the interests of the larger ones to a certain extent.

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Quite a few analysts cover the stock, so you could look into forecast growth quite easily.

Insider Ownership Of Repro Med Systems

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

Our information suggests that insiders maintain a significant holding in Repro Med Systems, Inc.. Insiders have a US$22m stake in this US$163m business. This may suggest that the founders still own a lot of shares. You can click here to see if they have been buying or selling.

General Public Ownership

The general public, who are usually individual investors, hold a 28% stake in Repro Med Systems. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

Next Steps:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Be aware that Repro Med Systems is showing 1 warning sign in our investment analysis , you should know about...

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.